We help eligible patients access Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) for the maintenance treatment of COPD and asthma for as little as $69.95 per month through manufacturer Patient Assistance Programs.
The Trelegy Ellipta Prescription Assistance Program is a manufacturer-sponsored initiative that provides this triple-therapy inhaler at no medication cost to qualifying patients. For commercially insured patients, a savings card reduces costs to as little as $0. Uninsured patients may pay as little as $35 per inhaler.
AffordMyPrescriptions ensures breathing is never held hostage by a price tag. For a flat $69.95 per month, our Patient Advocates manage every step of your enrollment.
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Walgreens | ~$680 | Save ~$610/mo |
| CVS Pharmacy | ~$673 | Save ~$603/mo |
| Walmart | ~$675 | Save ~$605/mo |
*Just a heads-up — retail prices are estimates based on public data and vary by pharmacy. AffordMyPrescriptions Advocacy Service bypasses this by using drug manufacturer programs to secure your medication directly at no cost or retail price.
1 Medications
2 Medications
3 Medications
4+ Medications
The Patient Assistance Program is free to apply and provides medication at no cost if approved. But the process involves detailed applications, prescriber coordination, documentation, and ongoing management. Our $69.95/month covers full advocacy: applications, doctor coordination,
documentation, refill management, and re-enrollment — so you focus on your health, not paperwork.
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Discount coupons from GoodRx and SingleCare can reduce the cost of Trulicity, and the manufacturer’s savings card offers eligible commercially insured patients costs as low as $25 per fill. These programs provide real help — but they have significant limitations for long-term diabetes treatment. Here’s why the PAP through AffordMyPrescriptions is the better solution for patients who qualify:
Eligibility is generally determined by annual household income levels. Most programs follow guidelines that include a limit of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements can vary, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation.
Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) is a prescription once-daily maintenance inhaler for COPD and asthma in adults. It is the only inhaler combining all three types of respiratory medication — ICS, LAMA, and LABA — in a single device.
How It Works:
Fluticasone furoate (ICS) reduces chronic airway inflammation. Umeclidinium (LAMA) blocks acetylcholine to relax airway muscles for 24 hours. Vilanterol (LABA) activates beta-2 receptors for additional bronchodilation through a different mechanism. Together, they provide comprehensive respiratory control.
Form and Use:
One inhalation once daily, at the same time each day. Available in 100/62.5/25 mcg (COPD and asthma) and 200/62.5/25 mcg (asthma). Rinse mouth after use.
Generic Availability:
As of April 2026, no generic is available. No FDA-approved generic equivalent has been announced. Breztri Aerosphere is an alternative triple-combination inhaler for COPD.
Warnings:
NOT a rescue inhaler. Always carry a separate rescue inhaler. Do not use with other inhalers containing a LABA or LAMA.
Approximately $580–$837 per inhaler. With GoodRx coupons, prices drop to approximately $617–$673. Through AffordMyPrescriptions, qualifying patients receive Trelegy at no medication cost for $69.95/month.
No. It is a once-daily maintenance inhaler. Always carry a separate rescue inhaler for sudden breathing problems.
No. No FDA-approved generic is available as of April 2026. Breztri Aerosphere is an alternative triple- therapy inhaler for COPD.
Our advocates explore every alternative — the $0 savings card, $35 uninsured pricing, GoodRx coupons, Breztri Aerosphere as an alternative, and generic budesonide/formoterol plus a separate LAMA inhaler.
Typically 2 to 4 weeks. Our advocates can help coordinate bridge supplies with your pulmonologist.
If you are struggling with the high cost of Trelegy Ellipta, our team may be able to help you access assistance programs designed to make medications more affordable. Check your eligibility today and take the first step toward reducing your prescription costs.
Start free by filling out a simple online form.
Our specialist will contact you for a quick welcome call.
Our team handles everything, so you can focus on your health.